A. Rauscher

458 total citations
21 papers, 340 citations indexed

About

A. Rauscher is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Rauscher has authored 21 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Rauscher's work include Radiopharmaceutical Chemistry and Applications (14 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Rauscher is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Rauscher collaborates with scholars based in France, United States and Netherlands. A. Rauscher's co-authors include Alain Faivre-Chauvet, Jacques Barbet, David M. Goldenberg, Françoise Kraeber‐Bodéré, Caroline Rousseau, Robert M. Sharkey, Caroline Bodet‐Milin, Mickaël Bourgeois, Éric Frampas and Thomas Carlier and has published in prestigious journals such as Cancer Research, Frontiers in Pharmacology and Journal of Nuclear Medicine.

In The Last Decade

A. Rauscher

20 papers receiving 331 citations

Peers

Countries citing papers authored by A. Rauscher

Since Specialization

Citations

This map shows the geographic impact of A. Rauscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rauscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rauscher more than expected).

Fields of papers citing papers by A. Rauscher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rauscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rauscher. The network helps show where A. Rauscher may publish in the future.

Co-authorship network of co-authors of A. Rauscher

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rauscher. A scholar is included among the top collaborators of A. Rauscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rauscher. A. Rauscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE) 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Caroline Rousseau, (unknown), (unknown), A. Rauscher, (unknown), Darian Rusu, (unknown), (unknown), (unknown), Nageh K. Allam, (unknown), Mario Campone, L. Campion, Françoise Kraeber‐Bodéré	0
2	Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET 2023 ·Cancers ·(unknown), Éric Frampas, Yann Touchefeu, Éric Mirallié, M. Le Bras, Hélène Senellart, A. Rauscher, (unknown), L. Campion, V. Rohmer, Olivier Couturier, Rachida Lebtahi, François Rouzet, Philippe Ruszniewski, Françoise Kraeber‐Bodéré, Mickaël Bourgeois, C. Ansquer	4
3	Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy 2023 ·Cancers ·(unknown), A. Rauscher, (unknown), S. Supiot, Franck Drouet, L. Campion, Caroline Rousseau	6
4	Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jonathan Vigne, (unknown), (unknown), (unknown), Valérie Ardisson, (unknown), (unknown), A. Rauscher, François Hallouard, (unknown), (unknown), (unknown), Alain Faivre-Chauvet, (unknown), (unknown), Denis Agostini, Rémy Morello	1
5	Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study 2021 ·Journal of Nuclear Medicine ·Caroline Bodet‐Milin, Alain Faivre-Chauvet, Thomas Carlier, C. Ansquer, A. Rauscher, Éric Frampas, Frédérique Toulgoat, Damien Masson, Mickaël Bourgeois, (unknown), V. Rohmer, Olivier Couturier, D. Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet, Françoise Kraeber‐Bodéré	15
6	Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer 2020 ·Journal of Nuclear Medicine ·Caroline Rousseau, David M. Goldenberg, (unknown), (unknown), (unknown), Ludovic Ferrer, (unknown), (unknown), Damien Masson, Mario Campone, A. Rauscher, Vincent Fleury, Catherine Labbé, (unknown), (unknown), Claire Toquet, Jacques Barbet, Robert M. Sharkey, L. Campion, Françoise Kraeber‐Bodéré	28
7	Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Yann Touchefeu, Clément Bailly, Éric Frampas, (unknown), Caroline Rousseau, Mickaël Bourgeois, Céline Bossard, Alain Faivre-Chauvet, A. Rauscher, Damien Masson, (unknown), (unknown), Thomas Carlier, Robert M. Sharkey, David M. Goldenberg, Jacques Barbet, Françoise Kraeber‐Bodéré, Caroline Bodet‐Milin	23
8	Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches 2019 ·Frontiers in Medicine ·Caroline Bodet‐Milin, Clément Bailly, Yann Touchefeu, Éric Frampas, Mickaël Bourgeois, A. Rauscher, Franck Lacœuille, D. Drui, Nicolas Arlicot, David M. Goldenberg, Alain Faivre-Chauvet, Jacques Barbet, Caroline Rousseau, Françoise Kraeber‐Bodéré	22
9	Preliminary results of a ⁶⁸Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making 2019 ·The Prostate ·Caroline Rousseau, (unknown), Ludovic Ferrer, Daniéla Rusu, A. Rauscher, (unknown), (unknown), (unknown), Vincent Fleury, (unknown), (unknown), (unknown), (unknown), L. Campion, Françoise Kraeber‐Bodéré	22
10	68Ga‐PSMA‐11 PET‐CT study in prostate cancer patients with biochemical recurrence and non‐contributive 18F‐Choline PET‐CT: Impact on therapeutic decision‐making and biomarker changes 2018 ·The Prostate ·(unknown), (unknown), Ludovic Ferrer, (unknown), Daniéla Rusu, A. Rauscher, (unknown), (unknown), (unknown), (unknown), (unknown), Françoise Kraeber‐Bodéré, L. Campion, Caroline Rousseau	14
11	Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and ⁶⁸Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial 2016 ·Journal of Nuclear Medicine ·Caroline Bodet‐Milin, Alain Faivre-Chauvet, Thomas Carlier, A. Rauscher, Mickaël Bourgeois, (unknown), V. Rohmer, Olivier Couturier, D. Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet, Françoise Kraeber‐Bodéré	50
12	A pretargeting system for tumor PET imaging and radioimmunotherapy 2015 ·Frontiers in Pharmacology ·(unknown), Caroline Rousseau, Caroline Bodet‐Milin, Éric Frampas, Alain Faivre-Chauvet, A. Rauscher, Robert M. Sharkey, David M. Goldenberg, (unknown), Jacques Barbet	41
13	Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA–In) 2015 ·Frontiers in Medicine ·A. Rauscher, (unknown), (unknown), Sébastien Gouard, Catherine Maurel, Jacques Barbet, Alain Faivre-Chauvet, Marie Mougin‐Degraef	7
14	68Ga somatostatin analog radiolabelling: The radiopharmacist's point of view 2015 ·Médecine Nucléaire ·(unknown), A. Rauscher, Franck Lacœuille, (unknown), Benjamin Guillet, (unknown)	2
15	Abstract P5-01-01: Pretargeted immuno-PET with an anti-carcinoembryonic antigen (CEA) bispecific antibody (BsMAb) and a 68Ga-labeled hapten-peptide compared to conventional imaging and FDG-PET in metastatic breast cancer patients (BC): First results 2015 ·Cancer Research ·Mario Campone, A. Rauscher, Alain Faivre-Chauvet, Thomas Carlier, Ludovic Ferrer, (unknown), David M. Goldenberg, Robert M. Sharkey, Jacques Barbet, Françoise Kraeber‐Bodéré, Caroline Rousseau	1
16	Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients 2015 ·Frontiers in Medicine ·Caroline Bodet‐Milin, Ludovic Ferrer, A. Rauscher, Damien Masson, Latifa Rbah‐Vidal, Alain Faivre-Chauvet, (unknown), Caroline Rousseau, J. Hureaux, Olivier Couturier, Pierre‐Yves Salaün, David M. Goldenberg, Robert M. Sharkey, Françoise Kraeber‐Bodéré, Jacques Barbet	29
17	Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody 2014 ·Nuclear Medicine and Biology ·A. Rauscher, (unknown), Catherine Maurel, Mike Maillasson, (unknown), (unknown), (unknown), Jacques Barbet, Alain Faivre-Chauvet, Marie Mougin‐Degraef	14
18	Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice 2013 ·Nuclear Medicine and Biology ·(unknown), (unknown), A. Rauscher, Mickaël Bourgeois, Cyrille Alliot, Louisa Barré, Jean‐François Gestin, Raphaël Tripier, Alain Faivre-Chauvet	32
19	In vivo ²¹²Pb/²¹²Bi generator using indium-DTPA-tagged liposomes 2011 ·Radiochimica Acta ·(unknown), Marie Mougin‐Degraef, Eliot Patrick Botosoa, A. Rauscher, (unknown), Jacques Barbet, Gilles Montavon	12
20	Similar effects of electroporational stress and treatment with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate on vimentin expression in mouse plasmacytoma cells 2000 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·A. Rauscher, G. Giese, Joachim Nickel, Peter Traub	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact